Foley & Lardner LLP Partner Stephen Maebius and Patent Agent Jennie Zheng contributed to an article in IEEE Pulse titled, “ Next Generation Bioprinted Products: Products of Nature or Patentable Innovation ” in Volume 14, Issue 1 of the publication.
The authors describe the process of bioprinting, and its present use cases to generate a diverse range of products like ear and bone and its future potential across further complex matters, including a wide range of human organs. They then discuss the many aspects of bioprinting that are patent eligible, and examine potential strategies that may allow U.S. patents to be granted even on the end products.
